Delta variant

AstraZeneca said new data from Public Health England (PHE) demonstrated COVID-19 Vaccine AstraZeneca, offers high levels of protection against the Delta variant. AstraZeneca vaccine is used in India as Covishield. Real-world data from PHE, demonstrated two doses of COVID-19 Vaccine AstraZeneca are 92% effective against hospitalization due to the Delta variant and showed no deaths among those vaccinated. The higher efficacy against severe disease and hospitalization is supported by recent data showing a strong T-cell response to COVID-19 Vaccine AstraZeneca, which should correlate with high and durable protection. Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, said: “This real-world evidence shows…